Comparison of efficacy and safety of ultraviolet A radiation versus ultraviolet B radiation in atopic dermatitis
Keywords:
Atopic dermatitis, UVA, UVB, efficacy, safetyAbstract
Objective To compare the efficacy and safety of ultraviolet A versus ultraviolet B in atopic dermatitis.Methods In this randomized trial, conducted in the Dermatology Department Unit-II, King Edward Medical University Mayo Hospital, Lahore, 60 patients with AD fulfilling the inclusion criteria were entered in the study. In group A, 30 patients were given UVA treatment. In group B, 30 patients were treated with UVB. The treatment was given thrice a week till clearance or for maximum of 12 weeks. Emollients were applied in both groups. Patients were assessed at 2nd, 4th, 6th, 8th, 10th and 12th weeks. After completion of treatment they were followed monthly for 3 months.Results 100% patients in group B (UVB) and 93% patients in group A (UVA) showed >50% reduction in SCORAD. Side effects were observed in 47% patients in group A (pigmentation being statistically significant) and 25% patients in group B in which serious side effects of erythema and burns were seen, though statistically insignificant.Conclusion Both UVA and UVB are equal in terms of efficacy. Pigmentation is more common with UVA while erythema and burns were only seen with UVB.References
Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
Friedmann PS, Holden CA. Atopic dermatitis. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology, 7th ed. London: Blackwell Science; 2004. P. 18.1-18.54.
Nasreen S, Wahid Z, Ahmed A. Atopic dermatitis: frequency of associated disorders in children. J Pak Assoc Dermatol. 2005;15:125-9.
Spergel JM, Paller AS. Atopic dermatitis and atopic march. J Allergy Clin Immunol. 2003;112:S118-27.
Leung D, Boguniewicz M, Howell M. New insights in atopic dermatitis. J Clin Invest. 2004;113:651-7.
Ahmed I, Ansari M, Malick K. Childhood eczema: a comparative analysis. J Pak Assoc Dermatol. 2003;13:164-70.
Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112;S128-39.
Selvaag E, Caspersen L, Bech-Thomsen N, Wulf HC. Optimized UVB treatment of atopic dermatitis using skin reflectance measurements. A controlled, left-right comparison trial. Acta Derm Venereol. 2005;85: 144-6.
Aubin F. Mechanism involved in ultraviolet light-induced immunosuppression. J Eur Dermatol. 2003;3:515-23.
Bieber T. Atopic Dermatitis. N Eng J Med. 2008;358:1483-94.
Kanwar AJ, De D. Epidemiology and clinical features of atopic dermatitis in India. Indian J Dermatol. 2011;56:471-5.
Jekler J, Larko O. Phototherapy for atopic dermatitis with UVA, low dose UVB and combined UVA and UVB: 2 paired comparison studies. Photodermatol Photoimmunol Photomed. 1991;8:151-6.
Jekler J, Larko O. UVA solarium vs UVB phototherapy of atopic dermatitis: a paired comparison study. Br J Dermatol. 1991;125:569-72.
Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet. 2001;357:2012-6.
Jekler J, Larko O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired-comparison study. J Am Acad Dermatol. 1990;22:49-53.
Falk ES. UV-light therapies in atopic dermatitis. Photodermatol. 1985;2:241-6.
Jekler J, Larko O. UVB phototherapy of atopic dermatitis. Br J Dermatol. 1988;119:697-705.